Clinical Trial Update: Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability study comparing a generic bicalutamide 50 mg tablet with Casodex (bicalutamide) after a 50 mg dose in healthy fasting subjects,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hirsutism
• Prostate Cancer

Drugs mentioned

• Bicalutamide 50 mg Tablet (Generic) (bicalutamide)
• Casodex (bicalutamide)

Snippet

Sponsor: Sandoz | Conditions: Prostate Cancer, Hirsutism | Phase 1 | Status: COMPLETED